These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12574541)

  • 1. Controversy: the essence of medical debate.
    Donnan GA; Davis SM
    Stroke; 2003 Feb; 34(2):372-3. PubMed ID: 12574541
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke: success for extending acute treatment.
    Lees KR
    Lancet Neurol; 2009 Jan; 8(1):2-4. PubMed ID: 19081499
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study): How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?
    Strbian D; Saposnik G
    Stroke; 2016 Dec; 47(12):3063-3064. PubMed ID: 27789665
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensuring patient safety in clinical trials for treatment of acute stroke.
    Becker KJ; Tirschwell DL
    JAMA; 2001 Dec; 286(21):2718-9. PubMed ID: 11730448
    [No Abstract]   [Full Text] [Related]  

  • 8. Subarachnoid hemorrhage--a rare complication after intravenous thrombolysis in an ischemic stroke patient.
    Chou CL; Lin YJ; Po HL; Chang CK
    Am J Emerg Med; 2010 Oct; 28(8):984.e1-3. PubMed ID: 20825835
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal outcome following thrombolysis for stroke secondary to infectious endocarditis.
    Fuentes Fernández I; Morales Ortíz A; Sanmartín Monzó J; Jara Rubio R
    Neurologia; 2016; 31(6):421-3. PubMed ID: 25542500
    [No Abstract]   [Full Text] [Related]  

  • 10. Danger of treatment protocols.
    Cucchiara B; Messé S; Kasner SE
    Stroke; 2003 May; 34(5):e19. PubMed ID: 12690208
    [No Abstract]   [Full Text] [Related]  

  • 11. Should physicians give tPA to patients with acute ischemic stroke? For: thrombolytics in stroke: whose risk is it anyway?
    Robinson DJ
    West J Med; 2000 Sep; 173(3):148-9. PubMed ID: 10986159
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 13. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro.
    Schellinger PD; Fiebach JB
    Stroke; 2005 May; 36(5):1104-5. PubMed ID: 15790944
    [No Abstract]   [Full Text] [Related]  

  • 14. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: con.
    Zivin JA
    Stroke; 2005 May; 36(5):1105-6. PubMed ID: 15790943
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroke thrombolysis in the elderly: risk or benefit?
    Hemphill JC; Lyden P
    Neurology; 2005 Dec; 65(11):1690-1. PubMed ID: 16344508
    [No Abstract]   [Full Text] [Related]  

  • 16. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
    Mooney T; Joseph P
    Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do risks outweigh benefits in thrombolysis for stroke?
    Brown SG; Macdonald SP; Hankey GJ
    BMJ; 2013 Aug; 347():f5215. PubMed ID: 23990634
    [No Abstract]   [Full Text] [Related]  

  • 19. Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation.
    Davis SM; Donnan GA
    Stroke; 2005 May; 36(5):1106-7. PubMed ID: 15802638
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous thrombolytic therapy for acute ischemic stroke.
    Wechsler LR
    N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.